Precision Gene-Based Therapy for Progressive Familial Intrahepatic Cholestasis: Matching Platform to Disease Biology

Progressive familial intrahepatic cholestasis (PFIC) encompasses genetically heterogeneous disorders affecting bile transport, membrane organisation, epithelial polarity and bile-acid signalling. Current medical and surgical treatments can improve symptoms and disease course in selected patients, but substantial unmet need remains, particularly in severe early-onset disease and multisystem disorders. This review considers the thirteen numbered PFIC subtypes and selected related monogenic cholestatic conditions, relating their mechanisms to gene addition, genome editing, splice correction, messenger RNA replacement and cell-based strategies. Published PFIC intervention evidence is predominantly preclinical, with proof of concept in selected mouse models and in vitro systems. Clinical experience in other liver diseases provides relevant delivery and safety precedents but does not establish efficacy in PFIC. Platform selection will depend on molecular mechanism, target tissue, therapeutic threshold, disease stage and the durability required during liver growth. Severe disease identifies unmet need rather than a proven optimal platform. We propose a framework for research prioritisation and identify the studies needed to establish sustained benefit, genomic and immunological safety, and clinically meaningful outcomes.

Authors

Publication Details

Journal
Biologics
Published
2026-11-13
DOI
https://doi.org/10.3390/biologics6040035
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Precision Gene-Based Therapy for Progressive Familial Intrahepatic Cholestasis: Matching Platform to Disease Biology

Andrei Claudiu Cozmescu, Paul Gissen, S. Tamir Rashid, Ziyu Jiang
Biologics
Drug Transport and Resistance Mechanisms
article

Precision Gene-Based Therapy for Progressive Familial Intrahepatic Cholestasis: Matching Platform to Disease Biology

Andrei Claudiu Cozmescu, Paul Gissen, S. Tamir Rashid, Ziyu Jiang
article en

Abstract

Progressive familial intrahepatic cholestasis (PFIC) encompasses genetically heterogeneous disorders affecting bile transport, membrane organisation, epithelial polarity and bile-acid signalling. Current medical and surgical treatments can improve symptoms and disease course in selected patients, but substantial unmet need remains, particularly in severe early-onset disease and multisystem disorders. This review considers the thirteen numbered PFIC subtypes and selected related monogenic cholestatic conditions, relating their mechanisms to gene addition, genome editing, splice correction, messenger RNA replacement and cell-based strategies. Published PFIC intervention evidence is predominantly preclinical, with proof of concept in selected mouse models and in vitro systems. Clinical experience in other liver diseases provides relevant delivery and safety precedents but does not establish efficacy in PFIC. Platform selection will depend on molecular mechanism, target tissue, therapeutic threshold, disease stage and the durability required during liver growth. Severe disease identifies unmet need rather than a proven optimal platform. We propose a framework for research prioritisation and identify the studies needed to establish sustained benefit, genomic and immunological safety, and clinically meaningful outcomes.

BiologicsVol. 6(4)
Alpha-1 Foundation, LifeArc, Action Medical Research, National Institute for Health and Care Research, Rosetrees Trust, Medical Research Council
Good health and well-being
Drug Transport and Resistance Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon